Cite
HARVARD Citation
Rao, Y. et al. (2019). Bouchardatine analogue alleviates non‐alcoholic hepatic fatty liver disease/non‐alcoholic steatohepatitis in high‐fat fed mice by inhibiting ATP synthase activity. British journal of pharmacology. pp. 2877-2893. [Online].